The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes (AddHope2)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Haugaard, Steen Bendix, M.D., DMSc
ClinicalTrials.gov Identifier:
NCT01595789
First received: May 8, 2012
Last updated: September 18, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)